DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tenormin (Atenolol) - Adverse Event Reports - Other Serious Reactions - Dyspnoea

 



Index of reports > Cases resulting in other serious reactions (30) > Cases with Dyspnoea (4)

Below is the selection of adverse event reports related to Tenormin (Atenolol) that includes cases resulting in other serious reactions where reactions include dyspnoea.

Adverse event in receiving Tenormin (Atenolol)

Reported by a consumer/non-health professional from France on 2007-10-22

Patient:

Adverse reactions / side effects: Cryptogenic Organising Pneumonia, Dyspnoea, Eosinophilic Pneumonia, Bronchomalacia, Asthenia, Cough

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-11-15
    End date: 2007-01-15

Tenormin
    Dosage: 1 u, qd
    Administration route: Oral
    Start date: 2006-11-15
    End date: 2007-06-13

Kardegic / 00002703 /
    Dosage: 160 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-11-15

Tahor
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2006-11-15

Plavix
    Dosage: 75 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-11-15
    End date: 2007-01-15



Adverse event in 57 year old male receiving Tenormin (Atenolol)

Reported by a pharmacist from Japan on 2007-10-02

Patient: 57 year old male, weighing 59.0 kg (129.8 pounds)

Adverse reactions / side effects: White Blood Cell Count Decreased, Dyspnoea, Pericardial Effusion, Haemoglobin Decreased, Haematocrit Decreased, Thrombocytopenic Purpura, Platelet Count Decreased, Haemorrhagic Diathesis, Rash Maculo-Papular

Adverse event resulted in: life threatening event

Suspect drug(s):
Lasix
    Dosage: 20 mg/day
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2007-06-12
    End date: 2007-07-13

Aldactone
    Dosage: 25 mg/day
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2007-06-27
    End date: 2007-07-20

Tenormin
    Dosage: 25 mg/day
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2004-04-01
    End date: 2007-07-20

Micardis
    Dosage: 20 mg/day
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2004-04-01
    End date: 2007-07-20

Warfarin Sodium
    Dosage: 3 mg/day
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2007-06-07
    End date: 2007-07-09

Propylthiouracil
    Dosage: 300 mg/day
    Administration route: Oral
    Start date: 1987-01-01
    End date: 2007-07-12

Propylthiouracil
    Dosage: 200 mg/day
    Administration route: Oral
    Start date: 2007-07-13
    End date: 2007-07-20

Propylthiouracil
    Dosage: 300 mg/day
    Administration route: Oral
    Start date: 2007-08-03

Mucosta
    Dosage: 300 mg/day
    Administration route: Oral
    Indication: Gastric Mucosal Lesion
    Start date: 2007-05-18
    End date: 2007-07-13

Sigmart
    Dosage: 15 mg/day
    Administration route: Oral
    Indication: Angina Pectoris
    Start date: 2004-04-01
    End date: 2007-07-13

Bepricor
    Dosage: 150 mg/day
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2007-07-02
    End date: 2007-07-20

Nitroderm
    Dosage: 1 patch/day
    Indication: Angina Pectoris
    Start date: 2007-07-13

Amlodipine Besylate
    Indication: Angina Pectoris
    Start date: 2004-04-01

Aspirin
    Dosage: 100mg
    Administration route: Oral
    End date: 2007-07-12

Other drugs received by patient: Unasyn; Gentacin



Adverse event in female receiving Tenormin (Atenolol)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-25

Patient: female, weighing 69.4 kg (152.7 pounds)

Adverse reactions / side effects: Dyspnoea, Disease Recurrence, Drug Ineffective, Arrhythmia

Suspect drug(s):
Tenormin (Atenolol)



Adverse event in male receiving Tenormin (Atenolol)

Reported by a physician from Japan on 2007-06-28

Patient: male

Adverse reactions / side effects: Dyspnoea, Pulmonary Oedema, Myelodysplastic Syndrome, Pleural Effusion, Neutrophil Count Decreased

Suspect drug(s):
Tenormin
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2007-06-10

Aspirin
    Administration route: Oral
    Start date: 2007-04-27
    End date: 2007-06-10

Bepricor
    Administration route: Oral
    Start date: 2007-04-27
    End date: 2007-06-10

Lendormin
    Administration route: Oral
    End date: 2007-06-10

Lipitor
    Administration route: Oral
    End date: 2007-06-10

Pletal
    Administration route: Oral

Sigmart
    Administration route: Oral
    Start date: 2007-04-27
    End date: 2007-06-10

Warfarin Potassium
    Administration route: Oral
    Start date: 2007-04-27
    End date: 2007-06-10

Zantac
    Administration route: Oral
    Start date: 2007-04-27
    End date: 2007-06-10

Other drugs received by patient: Furosemide; Ambroxol Hydrochloride

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009